Why You Probably Shouldn't Buy GoodRx Stock

Free digital coupons that lower prescription drug prices for consumers are awfully popular, but investors haven't been nearly as excited about the company producing most of those coupons, GoodRx (NASDAQ: GDRX). Shares of this complicated digital healthcare stock have traded mostly sideways since it made its debut on the public markets in September. 

In this video clip from a recently aired segment on Fool Live, Healthcare and Cannabis Bureau Chief Corinne Cardina and longtime Motley Fool contributor Cory Renauer discuss the GoodRx IPO. Tune in to the video clip to find out why everyday investors want to think twice before taking a chance on this digital health stock.

Continue reading

Source Fool.com